Development of a method for cancer risk assessment by genomic mutation analysis

A Study for the development of the method for cancer risk assessment using highly accurate genomic mutation analysis - Development of a method for cancer risk assessment by genomic mutation analysis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000039526

Enrollment

171

Registered

2020-02-18

Start date

2019-12-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adults, Cancer patients

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy males and females

Exclusion criteria

Exclusion criteria: Subjects deemed inappropriate to participate in this study by the principle investigator

Design outcomes

Primary

Measure	Time frame
Evaluation of the patterns, frequencies, positions and distributions of somatic mutations	—

Secondary

Measure	Time frame
1. Estimation of relevant environmental mutagens by the evaluation of the patterns and frequencies, or sequence context of somatic mutations 2. Estimation of mutation acquiring processes by the evaluation of positions of mutations and correlations to known epigenetic markers	—

Countries

Japan

Contacts

Public ContactShoji Matsumura

Kao Corporation Safety Science Research

matsumura.shouji@kao.com+81-70-3301-1852

Outcome results